![Chun Yu Pan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Chun Yu Pan
Direttore/Membro del Consiglio presso UWELL Biopharma, Inc.
Posizioni attive di Chun Yu Pan
Società | Posizione | Inizio | Fine |
---|---|---|---|
UWELL Biopharma, Inc.
![]() UWELL Biopharma, Inc. Pharmaceuticals: MajorHealth Technology UWELL Biopharma, Inc. is a biotech company founded in 2003 and based in New Taipei, Taiwan. The Taiwanese company specializes in developing new cancer drugs using chimeric antigen receptor T-cell (CAR-T) technology. CAR-T therapy involves engineering a patient's T-cells to recognize and attack cancer cells. UWELL is currently conducting an open, single-center phase I clinical trial to evaluate the safety and efficacy of its anti-CD19 CAR-T cell injection in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma. The study has been approved by the Institutional Review Board of Tri-Service General Hospital and the Ministry of Health and Welfare. UWELL has achieved success in treating adult blood cancer patients with CAR-T therapy, as evidenced by the clearance of cancer cells in the first case treated at Tri-Service General Hospital. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Chun Yu Pan
Precedenti posizioni note di Chun Yu Pan
Società | Posizione | Inizio | Fine |
---|---|---|---|
VECTORITE BIOMEDICAL INC. | Direttore/Membro del Consiglio | 03/06/2011 | - |
Public Communications Contact | - | - | |
Corporate Officer/Principal | 05/09/2014 | - | |
SHANGYA TECHNOLOGY CO., LTD. | Direttore/Membro del Consiglio | - | - |
Formazione di Chun Yu Pan
Chinese Culture University | Masters Business Admin |
Statistiche
Distribuzione geografica
Taiwan | 5 |
Posizioni
Director/Board Member | 3 |
Masters Business Admin | 1 |
Public Communications Contact | 1 |
Settori
Health Technology | 3 |
Consumer Services | 2 |
Transportation | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
SHANGYA TECHNOLOGY CO., LTD. | Health Technology |
VECTORITE BIOMEDICAL INC. | Transportation |
Aziende private | 1 |
---|---|
UWELL Biopharma, Inc.
![]() UWELL Biopharma, Inc. Pharmaceuticals: MajorHealth Technology UWELL Biopharma, Inc. is a biotech company founded in 2003 and based in New Taipei, Taiwan. The Taiwanese company specializes in developing new cancer drugs using chimeric antigen receptor T-cell (CAR-T) technology. CAR-T therapy involves engineering a patient's T-cells to recognize and attack cancer cells. UWELL is currently conducting an open, single-center phase I clinical trial to evaluate the safety and efficacy of its anti-CD19 CAR-T cell injection in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma. The study has been approved by the Institutional Review Board of Tri-Service General Hospital and the Ministry of Health and Welfare. UWELL has achieved success in treating adult blood cancer patients with CAR-T therapy, as evidenced by the clearance of cancer cells in the first case treated at Tri-Service General Hospital. | Health Technology |
- Borsa valori
- Insiders
- Chun Yu Pan
- Esperienza